Three providers for GLP-1 care in my state: can one replace them?

You keep three logins for one prescription. The insurance card in your wallet pays for a primary care physician who has said, politely, that a GLP-1 is not something they will prescribe. A membership app handles the medication. A telehealth prescriber you have met only through a form signs the order. So when you type something like "one clinician for GLP-1 care in my state" into a search bar, the question underneath is larger than geography: could all of this sit in one place, and would that place be allowed to treat you where you live?

On geography, the answer is short: GoodLife Health's clinicians are licensed in all fifty states. The longer answer is that "covered" means two different things for someone paying for care the way you are, and only one of them is GoodLife Health's to answer. This piece works through both with a composite patient we will call Maren, assembled from situations like yours; she is not a real person. It sets out what one membership would replace, what it costs, what it leaves exactly where it is, and who should not buy it.

Three providers, one prescription, and no one holding the chart

Maren's arrangement did not begin as a plan. It grew one gap at a time. Her primary care physician, the one her premium pays for, ordered a yearly panel, mentioned her weight, and declined to prescribe a GLP-1. She found a membership app that would. The app sent her to a telehealth prescriber who reviewed a questionnaire and signed. The medication started arriving, and for a few months that felt like the problem solved.

What she has now is three relationships, and none of them owns the outcome. The physician sees her once a year and keeps a medication list that includes the GLP-1 only if she remembered to mention it. The app knows her shipping address, her billing date and whatever she typed into its intake form. The prescriber has seen a questionnaire and perhaps one set of numbers she uploaded. When she feels unwell for a week after a dose change, she does not know whom to ask. When her physician's panel shows her lipids or her HbA1c moving, the person who sets her dose never sees the result.

There is a cost in money and a cost in attention. She pays a premium, a membership fee and whatever the medication costs, and on top of that she does the coordination herself: downloading a PDF from one portal to upload into another, retelling her history to whichever prescriber is on shift, deciding alone whether a symptom deserves a message and, if so, to whom. None of the three is failing by its own terms. Each was built to do one piece of the work, and the pieces were never designed to meet.

So when she starts looking for one clinician who could hold all of it, the first thing she checks is the practical thing. Some of the services she looked at showed a map of states with gaps in it. If her state is one of the gaps, nothing else about a new arrangement matters, so she asks that question before any other. It is a sensible order. It also turns out to be the easiest question in the whole decision, and answering it clears the ground for the harder ones.

What "covered" means here, and which part GoodLife Health can answer

The word "covered" is doing two jobs in Maren's question, and the two jobs have different answers. Pulling them apart is most of what she needs in order to decide well.

The first job is about the clinician. GoodLife Health's clinicians are licensed in all fifty states, and the care is delivered by telehealth, so Maren does not need an office nearby to become a patient. As What Is GoodLife Health? explains, clinicians practice independently in Arizona and California, with collaborating physicians elsewhere. Her lab draws happen at a LabCorp or Quest location rather than at a GoodLife Health clinic. Where she lives does not, by itself, decide whether she can be seen.

What decides that is a clinician. Not everyone is accepted. The path runs in a fixed order: the eligibility check, the intake, the checkout, and then a clinician's review of her history and her situation. Her state being open gets her to that review; it does not stand in for it.

The second job is about money, and it is the one her insurance premium has trained her to think of first. If a GoodLife Health clinician prescribes Wegovy or Zepbound, will her plan pay for it? GoodLife Health cannot answer that and does not try. Whether insurance covers a medication is between the patient, the plan and the pharmacy. Where a plan requires prior authorization, that is the pharmacy's process; GoodLife Health does not claim to run it, speed it or win it. A prescription can be clinically sound, written by a clinician licensed in her state, and still not be covered by her plan. Both can be true at the same moment, and it is better for Maren to know that before she signs up than after.

There is a narrower third point. A few medications depend on state law as well as clinical judgment. Testosterone is a Schedule III controlled substance, prescribed and dispensed only where federal and state law allow, through the clinical partner's arrangement; the membership never promises it, and the clinician decides. For Maren, whose question is a GLP-1, that is a side note. It does show what "my state is covered" actually describes: access to a licensed clinician, with no guarantee of any particular prescription.

With geography settled, the more useful question is why her care split into three pieces in the first place. The prescription came loose from the primary-care relationship. Her physician holds the relationship but will not prescribe. The app and its prescriber will prescribe but hold no relationship. What is missing is one clinician who orders the labs, reads them, makes the prescribing decision, and is still there three months later when the next panel comes back and the dose may need to change.

That gap is what Direct Primary Care is designed to close. GoodLife Health is precision direct primary care for cardiometabolic optimization, clinician-led and labs-first: diagnosis first, then treatment, then the long haul. The order matters for someone in Maren's position. In her current arrangement, treatment came first, and diagnosis, where it happened at all, happened in a different office whose results never reached the person writing the prescription.

What one membership would replace, and what it costs

The membership is $299 a month, month to month. At sign-up, $598 is charged, which covers the first two months. If the clinician cannot accept Maren into care, the $598 is refunded in full. Once she is accepted, the first two months are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy.

For that fee she gets clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in her own hands, asynchronous messaging with the care team, and video visits. The quarterly panels are GoodLife Health's Biomarker Audits. As What a Direct Primary Care Visit Actually Looks Like describes, the panel covers a metabolic panel, a lipid panel, HbA1c, a hormone panel, TSH, fasting insulin and a CBC, and it is ordered before the first visit so that the appointment starts with data rather than with a lab order and a wait. In that walkthrough, a first visit typically runs 45–60 minutes.

The fee is the same whatever medication is indicated and whatever the dose. There is no molecule upcharge and no dose upcharge, so a change from one GLP-1 to another, or a step up in dose, does not change what she pays GoodLife Health. That is what Medication-Neutral Pricing means in practice: the clinician's decision about the drug has no effect on what the practice earns.

Medication is unbundled. When a clinician judges it clinically indicated, the prescription goes to the pharmacy Maren chooses, at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. Prescriptions are for branded, FDA-approved medication only; for GLP-1, that means Wegovy, Zepbound, Mounjaro or Ozempic.

For a sense of scale, the manufacturers publish their own self-pay prices. As published in September 2026, NovoCare listed Wegovy pens at $199 a month for the first two fills, an introductory offer for new patients through December 2026, and $349 a month after that, with the Wegovy pill from $149 a month at lower doses. LillyDirect listed Zepbound vials at $299 to $449 a month depending on dose. Those are the manufacturers' figures, not GoodLife Health's, and they can change. Over a year, the membership itself is $3,588; a fair comparison with what Maren pays now would set her own full-year total for the app, the prescriber and the medication beside that figure, with the dates of the prices used. The membership fee is generally eligible for HSA or FSA pre-tax dollars.

Then there is what the membership leaves alone. It does not replace her insurance. The membership pairs with insurance for catastrophic coverage and replaces the primary-care relationship; Maren keeps her plan for specialists, hospital care and the emergency she hopes never comes. It does not promise that her plan will cover a GLP-1, or that a prior authorization will go through. It does not promise any amount of weight loss. It does not promise a prescription at all: the clinician reviews her labs and her history and decides what is indicated, and sometimes the answer will differ from what she expected.

What changes is where the chart lives. Instead of three partial records, there is one clinician holding her labs, her medication, her messages and her next panel. In the model the visit walkthrough describes, if she needs a specialist, the practice sends her labs, medications and a clinical summary ahead of the referral, so she is no longer the courier between offices.

Checking your own state, and the questions it leaves open

The state question has the quickest answer of anything here, and the eligibility check is where to get it for your own address. It comes first, before the intake and before the checkout. If your state is open, the next steps are the intake and the checkout, then a clinician's review. If the clinician cannot accept you, the $598 comes back in full; once you are accepted, the first two months are non-refundable.

The check cannot tell you whether your plan will pay for a medication. That question belongs to your plan and your pharmacy, and it is worth asking them directly, with the drug names in hand, before you count on an answer. It also cannot tell you what a clinician will recommend, because that depends on labs that have not been drawn yet.

It may help to know where the membership sits. GoodLife Health sits between the $20,000-a-year concierge practice and the $99-a-month compounded app, and says so. For someone in Maren's position, already paying a premium, an app and a prescriber, the question is whether one clinician-led membership is a better use of money than the app and the prescriber she pays for now. That is a judgment only she can make, with her own figures.

Who this is not for

If the most important thing is the lowest monthly number, this membership will not win on that measure. The app you use may cost less than $299 a month, and some apps supply compounded GLP-1 for less than any branded option. GoodLife Health prescribes branded, FDA-approved medication only and never compounded GLP-1. The FDA has published its concerns about unapproved GLP-1 drugs used for weight loss, and the manufacturers have gone to court over compounded copies; whatever a patient decides, the licence of the clinician who prescribes carries the responsibility. If a $99 compounded app is what you want, this is not the right fit, and that is a reasonable choice to make knowingly.

It is also not for someone looking for an insurance replacement; the membership does not replace insurance. It is not for someone who wants a guarantee that a particular drug will be prescribed, covered or approved through prior authorization, because none of those can be promised. And it is not for anyone who wants the prescription without the labs. The quarterly panels and the clinician who reads them are what the fee pays for; if you would rather skip them, you would be paying for the part you do not want.

Related Reading

• What Is GoodLife Health? Direct Primary Care, Explained (2026)
• What a Direct Primary Care Visit Actually Looks Like (2026)

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss